0001209191-20-046870.txt : 20200814
0001209191-20-046870.hdr.sgml : 20200814
20200814210009
ACCESSION NUMBER: 0001209191-20-046870
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200814
DATE AS OF CHANGE: 20200814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOBULSKY SUSAN
CENTRAL INDEX KEY: 0001820885
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 201107773
MAIL ADDRESS:
STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
STREET 2: 1551 EASTLAKE AVE E STE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-13
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001820885
BOBULSKY SUSAN
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
1551 EASTLAKE AVE E STE 200
SEATTLE
WA
98102
0
1
0
0
SVP, Diagnostics, clonoSEQ
Stock Option (Right to Buy)
39.50
2020-08-13
4
A
0
20000
0.00
A
2030-08-13
Common Stock
20000
20000
D
The options vest with respect to 1/4 of such shares on August 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
/s/ Susan Bobulsky by Eric Billings, Attorney-in-Fact
2020-08-14